These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26408930)

  • 1. Familial hypercholesterolaemia: A global call to arms.
    Vallejo-Vaz AJ; Kondapally Seshasai SR; Cole D; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Akram A; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Corral P; Descamps O; Dieplinger H; Durst R; Freiberger T; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Nilsson L; Nordestgaard BG; O'Donoghue JM; Sahebkar A; Schunkert H; Shehab A; Stoll M; Su TC; Susekov A; Widén E; Catapano AL; Ray KK
    Atherosclerosis; 2015 Nov; 243(1):257-9. PubMed ID: 26408930
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular epidemiology of familial hypercholesterolaemia.
    Defesche JC; Kastelein JJ
    Lancet; 1998 Nov; 352(9141):1643-4. PubMed ID: 9853432
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to drugs and diet in a compound heterozygote for familial hypercholesterolaemia.
    Gudnason V; Muller DP; Lloyd JK; Humphries SE
    Arch Dis Child; 1995 Dec; 73(6):538-40. PubMed ID: 8546515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation screening in patients for familial hypercholesterolaemia (ADH).
    Taylor A; Patel K; Tsedeke J; Humphries SE; Norbury G
    Clin Genet; 2010 Jan; 77(1):97-9. PubMed ID: 19843101
    [No Abstract]   [Full Text] [Related]  

  • 5. Excess Aortic Pathology Risk in Patients with Genetically Verified Familial Hypercholesterolaemia: A Prospective Norwegian Registry Study.
    Mundal LJ; Igland J; Leren TP; Retterstøl K
    Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):712-713. PubMed ID: 33485759
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel Data on the Prevalence, Identification, Scouting, and Treatment of Familial Hypercholesterolaemia.
    Doumas M; Imprialos K; Stavropoulos K; Athyros VG
    Curr Pharm Des; 2018; 24(31):3597-3598. PubMed ID: 30642238
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum].
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior Waluś B; Imiela J; Jankowski P; Kłosiewicz Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T;
    Kardiol Pol; 2013; 71(1):107-11. PubMed ID: 23348551
    [No Abstract]   [Full Text] [Related]  

  • 8. An update on familial hypercholesterolaemia.
    Ose L
    Ann Med; 1999 Apr; 31 Suppl 1():13-8. PubMed ID: 10342495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypercholesterolaemia: clinical features and management.
    Pottle A
    Nurs Stand; 2005 Dec 14-2006 Jan 3; 20(14-16):55-65; quiz 66. PubMed ID: 16372559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results from a family and DNA based active identification programme for familial hypercholesterolaemia.
    ten Asbroek AH; de Mheen PJ; Defesche JC; Kastelein JJ; Gunning-Schepers LJ
    J Epidemiol Community Health; 2001 Jul; 55(7):500-2. PubMed ID: 11413180
    [No Abstract]   [Full Text] [Related]  

  • 11. [Familial hypercholesterolemia--from gene defect to cholesterol accumulation].
    Kontula K
    Duodecim; 1992; 108(15):1301-3. PubMed ID: 1366089
    [No Abstract]   [Full Text] [Related]  

  • 12. Importance of early recognition of heterozygous familial hypercholesterolaemia.
    Ryan A; Byrne CD
    Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic variability in familial hypercholesterolaemia: an update.
    Jansen AC; van Wissen S; Defesche JC; Kastelein JJ
    Curr Opin Lipidol; 2002 Apr; 13(2):165-71. PubMed ID: 11891419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing homozygous familial hypercholesterolaemia from cradle to grave.
    Thompson GR
    Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LDLR variant T705I does not cause the typical phenotype of familial hypercholesterolaemia.
    Graham CA; Wright WT; McIlhatton BP; Young IS; Nicholls DP
    Atherosclerosis; 2006 Sep; 188(1):218-9. PubMed ID: 16735037
    [No Abstract]   [Full Text] [Related]  

  • 16. [Low density lipoprotein receptor and hypercholesterolemia].
    Bruckert E; Chapman J
    Rev Prat; 1994 May; 44(10):1287-93. PubMed ID: 7939186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial hyperlipidemia in the aged].
    Mabuchi H
    Nihon Ronen Igakkai Zasshi; 1993 Mar; 30(3):188-92. PubMed ID: 8331820
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial hypercholesterolaemia--a case report.
    Basu Mullick C; Basu Das B; Chatterjee S; Bhattacharya G; Biswas S
    J Indian Med Assoc; 2002 Nov; 100(11):667-8. PubMed ID: 12797640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the global care of familial hypercholesterolaemia: Starting the ball rolling.
    Ray KK; Watts GF
    Atherosclerosis; 2018 Oct; 277():230-233. PubMed ID: 30270053
    [No Abstract]   [Full Text] [Related]  

  • 20. Deletions of the low density lipoprotein receptor gene underlying familial hypercholesterolaemia: screening by polymerase chain reaction using pooled DNA and blood samples.
    Vuorio AF; Paulin L; Turtola H; Kontula K
    Mol Cell Probes; 1997 Feb; 11(1):65-70. PubMed ID: 9076717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.